<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38673384</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1660-4601</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Apr</Month><Day>12</Day></PubDate></JournalIssue><Title>International journal of environmental research and public health</Title><ISOAbbreviation>Int J Environ Res Public Health</ISOAbbreviation></Journal><ArticleTitle>Pathophysiological Mechanisms in Long COVID: A Mixed Method Systematic Review.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">473</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijerph21040473</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Long COVID (LC) is a global public health crisis affecting more than 70 million people. There is emerging evidence of different pathophysiological mechanisms driving the wide array of symptoms in LC. Understanding the relationships between mechanisms and symptoms helps in guiding clinical management and identifying potential treatment targets.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a mixed-methods systematic review with two stages: Stage one (Review 1) included only existing systematic reviews (meta-review) and Stage two (Review 2) was a review of all primary studies. The search strategy involved Medline, Embase, Emcare, and CINAHL databases to identify studies that described symptoms and pathophysiological mechanisms with statistical analysis and/or discussion of plausible causal relationships between mechanisms and symptoms. Only studies that included a control arm for comparison were included. Studies were assessed for quality using the National Heart, Lung, and Blood Institute quality assessment tools.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">19 systematic reviews were included in Review 1 and 46 primary studies in Review 2. Overall, the quality of reporting across the studies included in this second review was moderate to poor. The pathophysiological mechanisms with strong evidence were immune system dysregulation, cerebral hypoperfusion, and impaired gas transfer in the lungs. Other mechanisms with moderate to weak evidence were endothelial damage and hypercoagulation, mast cell activation, and auto-immunity to vascular receptors.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">LC is a complex condition affecting multiple organs with diverse clinical presentations (or traits) underpinned by multiple pathophysiological mechanisms. A 'treatable trait' approach may help identify certain groups and target specific interventions. Future research must include understanding the response to intervention based on these mechanism-based traits.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Diar Bakerly</LastName><ForeName>Nawar</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-2102-1997</Identifier><AffiliationInfo><Affiliation>Faculty of Science and Engineering, Manchester Metropolitan University, Manchester M15 6BH, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Northern Care Alliance NHS Foundation Trust, Salford M6 8HD, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Nikki</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Locomotion Study Patient Advisory Group, Leeds Institute of Rheumatic and Musculoskeletal Medicine, Level D, Martin Wing, Leeds General Infirmary, Leeds LS1 3EX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Darbyshire</LastName><ForeName>Julie L</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0002-7655-1963</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwon</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-2860-7280</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bullock</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Northern Care Alliance NHS Foundation Trust, Salford M6 8HD, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baley</LastName><ForeName>Sareeta</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Birmingham Community Healthcare NHS Trust, Birmingham B7 4BN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sivan</LastName><ForeName>Manoj</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0334-2968</Identifier><AffiliationInfo><Affiliation>Rehabilitation Medicine, University of Leeds, Leeds Teaching Hospitals and Leeds Community Healthcare NHS Trusts, Leeds LS11 0DL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delaney</LastName><ForeName>Brendan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Medical Informatics and Decision Making, Imperial College, London SW7 2AZ, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Environ Res Public Health</MedlineTA><NlmUniqueID>101238455</NlmUniqueID><ISSNLinking>1660-4601</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">brain fog</Keyword><Keyword MajorTopicYN="N">fatigue</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">pathophysiology</Keyword><Keyword MajorTopicYN="N">post COVID syndrome</Keyword><Keyword MajorTopicYN="N">treatable trait</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest relating to this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>4</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>27</Day><Hour>9</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>27</Day><Hour>9</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>27</Day><Hour>1</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38673384</ArticleId><ArticleId IdType="pmc">PMC11050596</ArticleId><ArticleId IdType="doi">10.3390/ijerph21040473</ArticleId><ArticleId IdType="pii">ijerph21040473</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>England Summary|Coronavirus (COVID-19) in the UK.  [(accessed on 30 January 2024)]; Available online:  https://coronavirus.data.gov.uk/</Citation></Reference><Reference><Citation>Coronavirus Disease (COVID-19): Post COVID-19 Condition.  [(accessed on 30 January 2024)].  Available online:  https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-post-covid-19-condition.</Citation></Reference><Reference><Citation>Prevalence of Ongoing Symptoms following Coronavirus (COVID-19) Infection in the UK&#x2014;Office for National Statistics.  [(accessed on 30 January 2024)]; Available online:  https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/datasets/alldatarelatingtoprevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk.</Citation></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;Em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M., Taylor S. NICE guideline on long covid. BMJ. 2020;371:m4938. doi: 10.1136/bmj.m4938.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m4938</ArticleId><ArticleId IdType="pubmed">33361141</ArticleId></ArticleIdList></Reference><Reference><Citation>Overview|COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19|Guidance|NICE.  [(accessed on 30 January 2024)].  Available online:  https://www.nice.org.uk/guidance/ng188.</Citation></Reference><Reference><Citation>Michelen M., Manoharan L., Elkheir N., Cheng V., Dagens A., Hastie C., O&#x2019;Hara M., Suett J., Dahmash D., Bugaeva P., et al. Characterising long COVID: A living systematic review. BMJ Glob. Health. 2021;6:e005427. doi: 10.1136/bmjgh-2021-005427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>SeyedAlinaghi S., Afsahi A.M., MohsseniPour M., Behnezhad F., Salehi M.A., Barzegary A., Mirzapour P., Mehraeen E., Dadras O. Late Complications of COVID-19; a Systematic Review of Current Evidence. Arch. Acad. Emerg. Med. 2021;9:e14. doi: 10.22037/aaem.v9i1.1058.</Citation><ArticleIdList><ArticleId IdType="doi">10.22037/aaem.v9i1.1058</ArticleId><ArticleId IdType="pmc">PMC7927752</ArticleId><ArticleId IdType="pubmed">33681819</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke H., Freeman A., Cellura D.C., Stuart B.L., Brendish N.J., Poole S., Phan H.T.T., Sheard N., Williams S., Spalluto C.M., et al. Inflammatory phenotyping predicts clinical outcome in COVID-19. Respir. Res. 2020;21:245. doi: 10.1186/s12931-020-01511-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-020-01511-z</ArticleId><ArticleId IdType="pmc">PMC7506817</ArticleId><ArticleId IdType="pubmed">32962703</ArticleId></ArticleIdList></Reference><Reference><Citation>Lusczek E.R., Ingraham N.E., Karam B.S., Proper J., Siegel L., Helgeson E.S., Lotfi-Emran S., Zolfaghari E.J., Jones E., Usher M.G., et al. Characterizing COVID-19 clinical phenotypes and associated comorbidities and complication profiles. PLoS ONE. 2021;16:e0248956. doi: 10.1371/journal.pone.0248956.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0248956</ArticleId><ArticleId IdType="pmc">PMC8011766</ArticleId><ArticleId IdType="pubmed">33788884</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva J.F., Hernandez-Romieu A.C., Browning S.D., Bruce B.B., Natarajan P., Morris S.B., Gold J.A.W., Fanfair R.N., Rogers-Brown J., Rossow J., et al. COVID-19 Clinical Phenotypes: Presentation and Temporal Progression of Disease in a Cohort of Hospitalized Adults in Georgia, United States. Open Forum Infect. Dis. 2021;8:ofaa596. doi: 10.1093/ofid/ofaa596.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofaa596</ArticleId><ArticleId IdType="pmc">PMC7798484</ArticleId><ArticleId IdType="pubmed">33537363</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Vlok M., Venter C., Bezuidenhout J.A., Laubscher G.J., Steenkamp J., Kell D.B. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc. Diabetol. 2021;20:172. doi: 10.1186/s12933-021-01359-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuwa H.A., Shaw T.N., Knight S.B., Wemyss K., McClure F.A., Pearmain L., Prise I., Jagger C., Morgan D.J., Khan S., et al. Alterations in T and B cell function persist in convalescent COVID-19 patients. Med. 2021;2:720&#x2013;735.e4. doi: 10.1016/j.medj.2021.03.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2021.03.013</ArticleId><ArticleId IdType="pmc">PMC8011689</ArticleId><ArticleId IdType="pubmed">33821250</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M., Parkin A., Makower S., Greenwood D.C. Post-COVID syndrome symptoms, functional disability, and clinical severity phenotypes in hospitalized and nonhospitalized individuals: A cross-sectional evaluation from a community COVID rehabilitation service. J. Med. Virol. 2021;94:1419&#x2013;1427. doi: 10.1002/jmv.27456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27456</ArticleId><ArticleId IdType="pmc">PMC8661751</ArticleId><ArticleId IdType="pubmed">34783052</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans R.A., McAuley H., Harrison E.M., Shikotra A., Singapuri A., Sereno M., Elneima O., Docherty A.B., I Lone N., Leavy O.C., et al. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): A UK multicentre, prospective cohort study. Lancet Respir. Med. 2021;9:1275&#x2013;1287. doi: 10.1016/S2213-2600(21)00383-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00383-0</ArticleId><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>Rachael E. (Leicester University, Leicester, UK). Tocilizumab in Post-Hospital Inflammatory Long Covid Study (PHOSP-I) Personal email communication. 2003.</Citation></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Covidence Systematic Review Software, Veritas Health Innovation, Melbourne, Australia.  [(accessed on 15 December 2023)].  Available online:  www.covidence.org.</Citation></Reference><Reference><Citation>Study Quality Assessment Tools|NHLBI, NIH.  [(accessed on 30 January 2024)]; Available online:  https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools.</Citation></Reference><Reference><Citation>Akbarialiabad H., Taghrir M.H., Abdollahi A., Ghahramani N., Kumar M., Paydar S., Razani B., Mwangi J., Asadi-Pooya A.A., Malekmakan L., et al. Long COVID, a comprehensive systematic scoping review. Infection. 2021;49:1163&#x2013;1186. doi: 10.1007/s15010-021-01666-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01666-x</ArticleId><ArticleId IdType="pmc">PMC8317481</ArticleId><ArticleId IdType="pubmed">34319569</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaya J.-M., Rojas M., Salinas M.L., Rodr&#xed;guez Y., Roa G., Lozano M., Rodr&#xed;guez-Jim&#xe9;nez M., Montoya N., Zapata E., Monsalve D.M., et al. Post-COVID syndrome. A case series and comprehensive review. Autoimmun. Rev. 2021;20:102947. doi: 10.1016/j.autrev.2021.102947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.102947</ArticleId><ArticleId IdType="pmc">PMC8428988</ArticleId><ArticleId IdType="pubmed">34509649</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergantini L., Mainardi A., D&#x2019;alessandro M., Cameli P., Bennett D., Bargagli E., Sestini P. Common Molecular Pathways Between Post-COVID19 Syndrome and Lung Fibrosis: A Scoping Review. Front. Pharmacol. 2022;13:748931. doi: 10.3389/fphar.2022.748931.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.748931</ArticleId><ArticleId IdType="pmc">PMC8931519</ArticleId><ArticleId IdType="pubmed">35308222</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D., Chalon P., Kohn L., Dauvrin M., Detollenaere J., de Noordhout C.M., Jong C.P.-D., Cleemput I., Heede K.V.D. Pathophysiology and mechanism of long COVID: A comprehensive review. Ann. Med. 2022;54:1473&#x2013;1487. doi: 10.1080/07853890.2022.2076901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F., Ling S., Lui L.M., Lee Y., Gill H., Teopiz K.M., Rodrigues N.B., Subramaniapillai M., Di Vincenzo J.D., Cao B., et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav. Immun. 2022;101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg M., Maralakunte M., Garg S., Dhooria S., Sehgal I., Bhalla A.S., Vijayvergiya R., Grover S., Bhatia V., Jagia P., et al. The conundrum of long-covid-19: A narrative review. Int. J. Gen. Med. 2021;14:2491&#x2013;2506. doi: 10.2147/IJGM.S316708.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S316708</ArticleId><ArticleId IdType="pmc">PMC8214209</ArticleId><ArticleId IdType="pubmed">34163217</ArticleId></ArticleIdList></Reference><Reference><Citation>Houben S., Bonnech&#xe8;re B. The Impact of COVID-19 Infection on Cognitive Function and the Implication for Rehabilitation: A Systematic Review and Meta-Analysis. Int. J. Environ. Res. Public Health. 2022;19:7748. doi: 10.3390/ijerph19137748.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19137748</ArticleId><ArticleId IdType="pmc">PMC9266128</ArticleId><ArticleId IdType="pubmed">35805406</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain N., Agarwala P., Iqbal K., Omar H.M.S., Jangid G., Patel V., Rathore S.S., Kumari C., Velasquez-Botero F., L&#xf3;pez G.A.B., et al. A systematic review of acute telogen effluvium, a harrowing post-COVID-19 manifestation. J. Med. Virol. 2022;94:1391&#x2013;1401. doi: 10.1002/jmv.27534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27534</ArticleId><ArticleId IdType="pubmed">34931698</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshee S., Vatti N., Chang C. Long-Term Effects of COVID-19. Mayo Clin. Proc. 2022;97:579&#x2013;599. doi: 10.1016/j.mayocp.2021.12.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.12.017</ArticleId><ArticleId IdType="pmc">PMC8752286</ArticleId><ArticleId IdType="pubmed">35246288</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer P.T., Hellwig S., Blazhenets G., Hosp J.A. Molecular imaging findings on acute and long-term effects of COVID-19 on the brain: A systematic review. J. Nucl. Med. 2022;63:971&#x2013;980. doi: 10.2967/jnumed.121.263085.</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.121.263085</ArticleId><ArticleId IdType="pmc">PMC9258567</ArticleId><ArticleId IdType="pubmed">35177424</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce J.D., Shen Q., Cintron S.A., Hiebert J.B. Post-COVID-19 Syndrome. Nurs. Res. 2022;71:164&#x2013;174. doi: 10.1097/NNR.0000000000000565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NNR.0000000000000565</ArticleId><ArticleId IdType="pubmed">34653099</ArticleId></ArticleIdList></Reference><Reference><Citation>Piri S.M., Edalatfar M., Shool S., Jalalian M.N., Tavakolpour S. A systematic review on the recurrence of SARS-CoV-2 virus: Frequency, risk factors, and possible explanations. Infect. Dis. 2021;53:315&#x2013;324. doi: 10.1080/23744235.2020.1871066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2020.1871066</ArticleId><ArticleId IdType="pmc">PMC7852280</ArticleId><ArticleId IdType="pubmed">33508989</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramadan M.S., Bertolino L., Zampino R., Durante-Mangoni E., Iossa D., Ursi M.P., D&#x2019;Amico F., Karruli A., Andini R., Bernardo M., et al. Cardiac sequelae after coronavirus disease 2019 recovery: A systematic review. Clin. Microbiol. Infect. 2021;27:1250&#x2013;1261. doi: 10.1016/j.cmi.2021.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.06.015</ArticleId><ArticleId IdType="pmc">PMC8220864</ArticleId><ArticleId IdType="pubmed">34171458</ArticleId></ArticleIdList></Reference><Reference><Citation>Renaud-Charest O., Lui L.M., Eskander S., Ceban F., Ho R., Di Vincenzo J.D., Rosenblat J.D., Lee Y., Subramaniapillai M., McIntyre R.S. Onset and frequency of depression in post-COVID-19 syndrome: A systematic review. J. Psychiatr. Res. 2021;144:129&#x2013;137. doi: 10.1016/j.jpsychires.2021.09.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2021.09.054</ArticleId><ArticleId IdType="pmc">PMC8482840</ArticleId><ArticleId IdType="pubmed">34619491</ArticleId></ArticleIdList></Reference><Reference><Citation>Salamanna F., Veronesi F., Martini L., Landini M.P., Fini M. Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review of the Current Data. Front. Med. 2021;8:653516. doi: 10.3389/fmed.2021.653516.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.653516</ArticleId><ArticleId IdType="pmc">PMC8129035</ArticleId><ArticleId IdType="pubmed">34017846</ArticleId></ArticleIdList></Reference><Reference><Citation>Sansone A., Mollaioli D., Limoncin E., Ciocca G., B&#x1eaf;c N.H., Cao T.N., Hou G., Yuan J., Zitzmann M., Giraldi A., et al. The Sexual Long COVID (SLC): Erectile Dysfunction as a Biomarker of Systemic Complications for COVID-19 Long Haulers. Sex. Med. Rev. 2022;10:271&#x2013;285. doi: 10.1016/j.sxmr.2021.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sxmr.2021.11.001</ArticleId><ArticleId IdType="pmc">PMC8604714</ArticleId><ArticleId IdType="pubmed">34933829</ArticleId></ArticleIdList></Reference><Reference><Citation>Tesarz J., Nees F. Pain, the brain, and SARS-CoV-2: Evidence for pain-specific alterations in brain-related structure&#x2013;function properties. Neuroforum. 2022;28:105&#x2013;116. doi: 10.1515/nf-2021-0034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/nf-2021-0034</ArticleId></ArticleIdList></Reference><Reference><Citation>Willi S., L&#xfc;thold R., Hunt A., H&#xe4;nggi N.V., Sejdiu D., Scaff C., Bender N., Staub K., Schlagenhauf P. COVID-19 sequelae in adults aged less than 50 years: A systematic review. Travel Med. Infect. Dis. 2021;40:101995. doi: 10.1016/j.tmaid.2021.101995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tmaid.2021.101995</ArticleId><ArticleId IdType="pmc">PMC7898978</ArticleId><ArticleId IdType="pubmed">33631340</ArticleId></ArticleIdList></Reference><Reference><Citation>Apple A.C., Oddi A., Peluso M.J., Asken B.M., Henrich T.J., Kelly J.D., Pleasure S.J., Deeks S.G., Allen I.E., Martin J.N., et al. Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID-19. Ann. Clin. Transl. Neurol. 2022;9:221&#x2013;226. doi: 10.1002/acn3.51498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51498</ArticleId><ArticleId IdType="pmc">PMC8862406</ArticleId><ArticleId IdType="pubmed">35043593</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaudry R.I., Brotto A.R., Varughese R.A., de Waal S., Fuhr D.P., Damant R.W., Ferrara G., Lam G.Y., Smith M.P., Stickland M.K. Persistent dyspnea after COVID-19 is not related to cardiopulmonary impairment; a cross-sectional study of persistently dyspneic COVID-19, non-dyspneic COVID-19 and controls. Front. Physiol. 2022;13:917886. doi: 10.3389/fphys.2022.917886.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2022.917886</ArticleId><ArticleId IdType="pmc">PMC9297912</ArticleId><ArticleId IdType="pubmed">35874528</ArticleId></ArticleIdList></Reference><Reference><Citation>Besteher B., Machnik M., Troll M., Toepffer A., Zerekidze A., Rockt&#xe4;schel T., Heller C., Kikinis Z., Brodoehl S., Finke K., et al. Larger gray matter volumes in neuropsychiatric long-COVID syndrome. Psychiatry Res. 2022;317:114836. doi: 10.1016/j.psychres.2022.114836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2022.114836</ArticleId><ArticleId IdType="pmc">PMC9444315</ArticleId><ArticleId IdType="pubmed">36087363</ArticleId></ArticleIdList></Reference><Reference><Citation>Chudzik M., Cender A., Mordaka R., Zielinski J., Katarzynska J., Marcinek A., Gebicki J. Chronic Fatigue Associated with Post-COVID Syndrome versus Transient Fatigue Caused by High-Intensity Exercise: Are They Comparable in Terms of Vascular Effects? Vasc. Health Risk Manag. 2022;18:711&#x2013;719. doi: 10.2147/VHRM.S371468.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/VHRM.S371468</ArticleId><ArticleId IdType="pmc">PMC9464031</ArticleId><ArticleId IdType="pubmed">36097586</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark D.E., Dendy J.M., Li D.L., Crum K., Dixon D., George-Durrett K., Parikh A.P., Wassenaar J.W., Hughes S.G., Soslow J.H. Cardiovascular magnetic resonance evaluation of soldiers after recovery from symptomatic SARS-CoV-2 infection: A case&#x2013;control study of cardiovascular post-acute sequelae of SARS-CoV-2 infection (CV PASC) J. Cardiovasc. Magn. Reson. 2021;23:106&#x2013;109. doi: 10.1186/s12968-021-00798-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-021-00798-1</ArticleId><ArticleId IdType="pmc">PMC8495668</ArticleId><ArticleId IdType="pubmed">34620179</ArticleId></ArticleIdList></Reference><Reference><Citation>Crunfli F., Carregari V.C., Veras F.P., Silva L.S., Nogueira M.H., Antunes A.S.L.M., Vendramini P.H., Valen&#xe7;a A.G.F., Brand&#xe3;o-Teles C., Zuccoli G.d.S., et al. Morphological, cellular, and molecular basis of brain infection in COVID-19 patients. Proc. Natl. Acad. Sci. USA. 2022;119:e2200960119. doi: 10.1073/pnas.2200960119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2200960119</ArticleId><ArticleId IdType="pmc">PMC9436354</ArticleId><ArticleId IdType="pubmed">35951647</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A., Cuthbertson D.J., Wootton D., Crooks M., Gabbay M., Eichert N., Mouchti S., Pansini M., Roca-Fernandez A., Thomaides-Brears H., et al. Multi-organ impairment and long COVID: A 1-year prospective, longitudinal cohort study. J. R. Soc. Med. 2023;116:97&#x2013;112. doi: 10.1177/01410768231154703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768231154703</ArticleId><ArticleId IdType="pmc">PMC10041626</ArticleId><ArticleId IdType="pubmed">36787802</ArticleId></ArticleIdList></Reference><Reference><Citation>Durstenfeld M., Peluso M., Win S., Deeks S., Hsue P.Y. ROLE OF Antibodies, Inflammatory Markers, and Echocardiographic Findings in Post-Acute Cardiopulmonary Symptoms after SARS-CoV-2 Infection. J. Am. Coll. Cardiol. 2022;79:2108. doi: 10.1016/S0735-1097(22)03099-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(22)03099-6</ArticleId><ArticleId IdType="pmc">PMC9220849</ArticleId><ArticleId IdType="pubmed">35389890</ArticleId></ArticleIdList></Reference><Reference><Citation>Durstenfeld M.S., Peluso M.J., Kaveti P., Hill C., Li D., Sander E., Swaminathan S., Arechiga V.M., Lu S., A Goldberg S., et al. Reduced Exercise Capacity, Chronotropic Incompetence, and Early Systemic Inflammation in Cardiopulmonary Phenotype Long Coronavirus Disease 2019. J. Infect. Dis. 2023;228:542&#x2013;554. doi: 10.1093/infdis/jiad131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiad131</ArticleId><ArticleId IdType="pmc">PMC10686699</ArticleId><ArticleId IdType="pubmed">37166076</ArticleId></ArticleIdList></Reference><Reference><Citation>Fancourt D., Steptoe A., Bu F. Psychological consequences of long COVID: Comparing trajectories of depressive and anxiety symptoms before and after contracting SARS-CoV-2 between matched long- and short-COVID groups. Br. J. Psychiatry. 2023;222:74&#x2013;81. doi: 10.1192/bjp.2022.155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.2022.155</ArticleId><ArticleId IdType="pmc">PMC7614126</ArticleId><ArticleId IdType="pubmed">36458509</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrando S.J., Dornbush R., Lynch S., Shahar S., Klepacz L., Karmen C.L., Chen D., Lobo S.A., Lerman D. Neuropsychological, Medical, and Psychiatric Findings after Recovery from Acute COVID-19: A Cross-sectional Study. J. Acad. Consult. Liaison Psychiatry. 2022;63:474&#x2013;484. doi: 10.1016/j.jaclp.2022.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaclp.2022.01.003</ArticleId><ArticleId IdType="pmc">PMC8786396</ArticleId><ArticleId IdType="pubmed">35085824</ArticleId></ArticleIdList></Reference><Reference><Citation>Files J.K., Sarkar S., Fram T.R., Boppana S., Sterrett S., Qin K., Bansal A., Long D.M., Sabbaj S., Kobie J.J., et al. Duration of post-COVID-19 symptoms are associated with sustained SARS-CoV-2 specific immune responses. J. Clin. Investig. 2021;6:e151544. doi: 10.1172/jci.insight.151544.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.151544</ArticleId><ArticleId IdType="pmc">PMC8410022</ArticleId><ArticleId IdType="pubmed">34143754</ArticleId></ArticleIdList></Reference><Reference><Citation>Flaskamp L., Roubal C., Uddin S., Sotzny F., Kedor C., Bauer S., Scheibenbogen C., Seifert M. Serum of Post-COVID-19 Syndrome Patients with or without ME/CFS Differentially Affects Endothelial Cell Function In Vitro. Cells. 2022;11:2376. doi: 10.3390/cells11152376.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11152376</ArticleId><ArticleId IdType="pmc">PMC9367589</ArticleId><ArticleId IdType="pubmed">35954219</ArticleId></ArticleIdList></Reference><Reference><Citation>Finlay J.B., Brann D.H., Abi-Hachem R., Jang D.W., Oliva A.D., Ko T., Gupta R., Wellford S.A., Moseman E.A., Jang S.S., et al. Persistent Post-COVID-19 Smell Loss Is Associated with Inflammatory Infiltration and Altered Olfactory Epithelium. Sci Transl. Med. 2022;14:eadd0484. doi: 10.1126/scitranslmed.add0484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.add0484</ArticleId><ArticleId IdType="pmc">PMC10317309</ArticleId><ArticleId IdType="pubmed">36542694</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H., Townsend L., Morrin H., Ahmad A., Comerford C., Karampini E., Englert H., Byrne M., Bergin C., O&#x2019;sullivan J.M., et al. Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J. Thromb. Haemost. 2021;19:2546&#x2013;2553. doi: 10.1111/jth.15490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15490</ArticleId><ArticleId IdType="pmc">PMC8420256</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Gal&#xe1;n M., Vig&#xf3;n L., Fuertes D., Murciano-Ant&#xf3;n M.A., Casado-Fern&#xe1;ndez G., Dom&#xed;nguez-Mateos S., Mateos E., Ramos-Mart&#xed;n F., Planelles V., Torres M., et al. Persistent Overactive Cytotoxic Immune Response in a Spanish Cohort of Individuals with Long-COVID: Identification of Diagnostic Biomarkers. Front. Immunol. 2022;13:848886. doi: 10.3389/fimmu.2022.848886.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.848886</ArticleId><ArticleId IdType="pmc">PMC8990790</ArticleId><ArticleId IdType="pubmed">35401523</ArticleId></ArticleIdList></Reference><Reference><Citation>Giron L.B., Peluso M.J., Ding J., Kenny G., Zilberstein N.F., Koshy J., Hong K.Y., Rasmussen H., Miller G.E., Bishehsari F., et al. Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-kappaB signaling. J. Clin. Investig. 2022;7:e160989. doi: 10.1172/jci.insight.160989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.160989</ArticleId><ArticleId IdType="pmc">PMC9462470</ArticleId><ArticleId IdType="pubmed">35727635</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynne P., Tahmasebi N., Gant V., Gupta R. Long COVID following mild SARS-CoV-2 infection: Characteristic T cell alterations and response to antihista-mines. J. Investig. Med. 2022;70:61&#x2013;67. doi: 10.1136/jim-2021-002051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jim-2021-002051</ArticleId><ArticleId IdType="pmc">PMC8494538</ArticleId><ArticleId IdType="pubmed">34611034</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorecka M., Jex N., Thirunavukarasu S., Chowdhary A., Corrado J., Davison J., Tarrant R., Poenar A.-M., Sharrack N., Parkin A., et al. Cardiovascular magnetic resonance imaging and spectroscopy in clinical long-COVID-19 syndrome: A prospective case&#x2013;control study. J. Cardiovasc. Magn. Reson. 2022;24:50. doi: 10.1186/s12968-022-00887-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-022-00887-9</ArticleId><ArticleId IdType="pmc">PMC9464490</ArticleId><ArticleId IdType="pubmed">36089591</ArticleId></ArticleIdList></Reference><Reference><Citation>Grist J.T., Collier G.J., Walters H., Kim M., Chen M., Abu Eid G., Laws A., Matthews V., Jacob K., Cross S., et al. Lung Abnormalities Detected with Hyperpolarized 129Xe MRI in Patients with Long COVID. Radiology. 2022;305:709&#x2013;717. doi: 10.1148/radiol.220069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.220069</ArticleId><ArticleId IdType="pmc">PMC9134268</ArticleId><ArticleId IdType="pubmed">35608443</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo P., Ballesteros A.B., Yeung S.P., Liu R., Saha A., Curtis L., Kaser M., Haggard M.P., Cheke L.G. COVCOG 2: Cognitive and Memory Deficits in Long COVID: A Second Publication from the COVID and Cognition Study. Front. Aging Neurosci. 2022;14:804937. doi: 10.3389/fnagi.2022.804937.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.804937</ArticleId><ArticleId IdType="pmc">PMC8967943</ArticleId><ArticleId IdType="pubmed">35370620</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes E., Wist J., Masuda R., Lodge S., Nitschke P., Kimhofer T., Loo R.L., Begum S., Boughton B., Yang R., et al. Incomplete Systemic Recovery and Metabolic Phenoreversion in Post-Acute-Phase Nonhospitalized COVID-19 Patients: Implications for Assessment of Post-Acute COVID-19 Syndrome. J. Proteome Res. 2021;20:3315&#x2013;3329. doi: 10.1021/acs.jproteome.1c00224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.1c00224</ArticleId><ArticleId IdType="pubmed">34009992</ArticleId></ArticleIdList></Reference><Reference><Citation>Izzo R., Trimarco V., Mone P., Alo&#xe8; T., Marzani M.C., Diana A., Fazio G., Mallardo M., Maniscalco M., Marazzi G., et al. Combining L-Arginine with vitamin C improves long-COVID symptoms: The LINCOLN Survey. Pharmacol. Res. 2022;183:106360. doi: 10.1016/j.phrs.2022.106360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2022.106360</ArticleId><ArticleId IdType="pmc">PMC9295384</ArticleId><ArticleId IdType="pubmed">35868478</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J., Wood J., Jaycox J.R., Dhodapkar R.M., Lu P., Gehlhausen J.R., Tabachnikova A., Greene K., Tabacof L., Malik A.A., et al. Distinguishing features of long COVID identified through immune profiling. Nature. 2023;623:139&#x2013;148. doi: 10.1038/s41586-023-06651-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06651-y</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Kravchenko D., Isaak A., Zimmer S., Mesropyan N., Reinert M., Faron A., Pieper C.C., Heine A., Velten M., Nattermann J., et al. Cardiac MRI in Patients with Prolonged Cardiorespiratory Symptoms after Mild to Moderate COVID-19. Radiology. 2021;301:E419&#x2013;E425. doi: 10.1148/radiol.2021211162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021211162</ArticleId><ArticleId IdType="pmc">PMC8369880</ArticleId><ArticleId IdType="pubmed">34374593</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y., Riskedal E., Kalleberg K.T., Istre M., Lind A., Lund-Johansen F., Reiakvam O., S&#xf8;raas A.V.L., Harris J.R., Dahl J.A., et al. EWAS of post-COVID-19 patients shows methylation differences in the immune-response associated gene, IFI44L, three months after COVID-19 infection. Sci. Rep. 2022;12:11478. doi: 10.1038/s41598-022-15467-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-15467-1</ArticleId><ArticleId IdType="pmc">PMC9261254</ArticleId><ArticleId IdType="pubmed">35798818</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehmann A., Gysan M., Bernitzky D., Bal C., Prosch H., Zehetmayer S., Milos R.-I., Vonbank K., Pohl W., Idzko M., et al. Comparison of pulmonary function test, diffusion capacity, blood gas analysis and CT scan in patients with and without persistent respiratory symptoms following COVID-19. BMC Pulm. Med. 2022;22:196. doi: 10.1186/s12890-022-01987-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12890-022-01987-z</ArticleId><ArticleId IdType="pmc">PMC9109200</ArticleId><ArticleId IdType="pubmed">35578190</ArticleId></ArticleIdList></Reference><Reference><Citation>Littlefield K.M., Watson R.O., Schneider J.M., Neff C.P., Yamada E., Zhang M., Campbell T.B., Falta M.T., Jolley S.E., Fontenot A.P., et al. SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2. PLOS Pathog. 2022;18:e1010359. doi: 10.1371/journal.ppat.1010359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010359</ArticleId><ArticleId IdType="pmc">PMC9176759</ArticleId><ArticleId IdType="pubmed">35617421</ArticleId></ArticleIdList></Reference><Reference><Citation>Maamar M., Artime A., Pariente E., Fierro P., Ruiz Y., Guti&#xe9;rrez S., Tobalina M., D&#xed;az-Salazar S., Ramos C., Olmos J.M., et al. Post-COVID-19 syndrome, low-grade inflammation and inflammatory markers: A cross-sectional study. Curr. Med. Res. Opin. 2022;38:901&#x2013;909. doi: 10.1080/03007995.2022.2042991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03007995.2022.2042991</ArticleId><ArticleId IdType="pmc">PMC8935459</ArticleId><ArticleId IdType="pubmed">35166141</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M., Al-Rubaye H.T., Almulla A.F., Al-Hadrawi D.S., Stoyanova K., Kubera M., Al-Hakeim H.K. Lowered Quality of Life in Long COVID Is Predicted by Affective Symptoms, Chronic Fatigue Syndrome, Inflammation and Neuroimmunotoxic Pathways. Int. J. Environ. Res. Public Health. 2022;19:10362. doi: 10.3390/ijerph191610362.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191610362</ArticleId><ArticleId IdType="pmc">PMC9408685</ArticleId><ArticleId IdType="pubmed">36011997</ArticleId></ArticleIdList></Reference><Reference><Citation>Martini A.L., Carli G., Kiferle L., Piersanti P., Palumbo P., Morbelli S., Calcagni M.L., Perani D., Sestini S. Time-dependent recovery of brain hypometabolism in neuro-COVID-19 patients. Eur. J. Nucl. Med. Mol. Imaging. 2022;50:90&#x2013;102. doi: 10.1007/s00259-022-05942-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-022-05942-2</ArticleId><ArticleId IdType="pmc">PMC9388976</ArticleId><ArticleId IdType="pubmed">35984451</ArticleId></ArticleIdList></Reference><Reference><Citation>Matheson A.M., McIntosh M.J., Kooner H.K., Lee J., Desaigoudar V., Bier E., Driehuys B., Svenningsen S., Santyr G.E., Kirby M., et al. Persistent 129Xe MRI Pulmonary and CT Vascular Abnormalities in Symptomatic Individuals with Post-Acute COVID-19 Syndrome. Radiology. 2022;305:466&#x2013;476. doi: 10.1148/radiol.220492.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.220492</ArticleId><ArticleId IdType="pmc">PMC9272782</ArticleId><ArticleId IdType="pubmed">35762891</ArticleId></ArticleIdList></Reference><Reference><Citation>Munker D., Veit T., Barton J., Mertsch P., M&#xfc;mmler C., Osterman A., Khatamzas E., Barnikel M., Hellmuth J.C., M&#xfc;nchhoff M., et al. Pulmonary function impairment of asymptomatic and persistently symptomatic patients 4 months after COVID-19 according to disease severity. Infection. 2022;50:157&#x2013;168. doi: 10.1007/s15010-021-01669-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01669-8</ArticleId><ArticleId IdType="pmc">PMC8318328</ArticleId><ArticleId IdType="pubmed">34322859</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson B.K., Francisco E.B., Yogendra R., Long E., Pise A., Rodrigues H., Hall E., Herrera M., Parikh P., Guevara-Coto J., et al. Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection. Front. Immunol. 2021;12:746021. doi: 10.3389/fimmu.2021.746021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.746021</ArticleId><ArticleId IdType="pmc">PMC8784688</ArticleId><ArticleId IdType="pubmed">35082777</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Lu S., Tang A.F., Durstenfeld M.S., Ho H.-E., A Goldberg S., A Forman C., E Munter S., Hoh R., Tai V., et al. Markers of Immune Activation and Inflammation in Individuals with Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection. J. Infect. Dis. 2021;224:1839&#x2013;1848. doi: 10.1093/infdis/jiab490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab490</ArticleId><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Deveau T.-M., Munter S.E., Ryder D., Buck A., Beck-Engeser G., Chan F., Lu S., Goldberg S.A., Hoh R., et al. Chronic viral coinfections differentially affect the likelihood of developing long COVID. J. Clin. Investig. 2023:133. doi: 10.1172/JCI163669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI163669</ArticleId><ArticleId IdType="pmc">PMC9888380</ArticleId><ArticleId IdType="pubmed">36454631</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Sans H.M., Forman C.A., Nylander A.N., Ho H.-E., Lu S., Goldberg S.A., Hoh R., Tai V., Munter S.E., et al. Plasma Markers of Neurologic Injury and Inflammation in People with Self-Reported Neurologic Postacute Sequelae of SARS-CoV-2 Infection. Neurol. Neuroimmunol. Neuroinflamm. 2022;9:e200003. doi: 10.1212/NXI.0000000000200003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000200003</ArticleId><ArticleId IdType="pmc">PMC9210548</ArticleId><ArticleId IdType="pubmed">35701186</ArticleId></ArticleIdList></Reference><Reference><Citation>Roca-Fernandez A., Wamil M., Telford A., Carapella V., Borlotti A., Monteiro D., Thomaides-Brears H., Dennis A., Banerjee R., Robson M.D., et al. Cardiac impairment in Long Covid 1-year post SARS-CoV-2 infection. Eur. Heart J. 2022;43:ehac544.219. doi: 10.1093/eurheartj/ehac544.219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac544.219</ArticleId><ArticleId IdType="pmc">PMC9950586</ArticleId><ArticleId IdType="pubmed">36822818</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C., Willscher E., Paschold L., Gottschick C., Klee B., Henkes S.-S., Bosurgi L., Dutzmann J., Sedding D., Frese T., et al. The IL-1&#x3b2;, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep. Med. 2022;3:100663. doi: 10.1016/j.xcrm.2022.100663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100663</ArticleId><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh I., Joseph P., Heerdt P.M., Cullinan M., Lutchmansingh D.D., Gulati M., Possick J.D., Systrom D.M., Waxman A.B. Persistent Exertional Intolerance after COVID-19: Insights from Invasive Cardiopulmonary Exercise Testing. Chest. 2021;161:54&#x2013;63. doi: 10.1016/j.chest.2021.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.08.010</ArticleId><ArticleId IdType="pmc">PMC8354807</ArticleId><ArticleId IdType="pubmed">34389297</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollini M., Ciccarelli M., Cecconi M., Aghemo A., Morelli P., Gelardi F., Chiti A. Vasculitis changes in COVID-19 survivors with persistent symptoms: An [18F]FDG-PET/CT study. Eur. J. Nucl. Med. 2020;48:1460&#x2013;1466. doi: 10.1007/s00259-020-05084-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-020-05084-3</ArticleId><ArticleId IdType="pmc">PMC7595761</ArticleId><ArticleId IdType="pubmed">33123760</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollini M., Morbelli S., Ciccarelli M., Cecconi M., Aghemo A., Morelli P., Chiola S., Gelardi F., Chiti A. Long COVID hallmarks on [18F]FDG-PET/CT: A case-control study. Eur. J. Nucl. Med. 2021;48:3187&#x2013;3197. doi: 10.1007/s00259-021-05294-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05294-3</ArticleId><ArticleId IdType="pmc">PMC7937050</ArticleId><ArticleId IdType="pubmed">33677642</ArticleId></ArticleIdList></Reference><Reference><Citation>Talla A., Vasaikar S.V., Szeto G.L., Lemos M.P., Czartoski J.L., MacMillan H., Moodie Z., Cohen K.W., Fleming L.B., Thomson Z., et al. Persistent serum protein signatures define an inflammatory subset of long COVID. bioRxiv. 2022:2022-05. doi: 10.1101/2022.05.09.491196.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.05.09.491196</ArticleId><ArticleId IdType="pmc">PMC10252177</ArticleId><ArticleId IdType="pubmed">37296110</ArticleId></ArticleIdList></Reference><Reference><Citation>Visvabharathy L., Hanson B.A., Orban Z.S., Lim P.H., Palacio N.M., Jimenez M., Clark J.R., Graham E.L., Liotta E.M., Tachas G., et al. Neuro-PASC is characterized by enhanced CD4+ and diminished CD8+ T cell responses to SARS-CoV-2 Nucleocapsid protein. Front. Immunol. 2023;14:1155770. doi: 10.3389/fimmu.2023.1155770.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1155770</ArticleId><ArticleId IdType="pmc">PMC10258318</ArticleId><ArticleId IdType="pubmed">37313412</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstock L.B., Brook J.B., Walters A.S., Goris A., Afrin L.B., Molderings G.J. Mast cell activation symptoms are prevalent in Long-COVID. Int. J. Infect. Dis. 2021;112:217&#x2013;226. doi: 10.1016/j.ijid.2021.09.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.09.043</ArticleId><ArticleId IdType="pmc">PMC8459548</ArticleId><ArticleId IdType="pubmed">34563706</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu J.Z., Granberg T., Shams R., Petersson S., Sk&#xf6;ld M., Nyr&#xe9;n S., Lundberg J. Lung perfusion disturbances in nonhospitalized post-COVID with dyspnea&#x2014;A magnetic resonance imaging feasibility study. J. Intern. Med. 2022;292:941&#x2013;956. doi: 10.1111/joim.13558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13558</ArticleId><ArticleId IdType="pmc">PMC9539011</ArticleId><ArticleId IdType="pubmed">35946904</ArticleId></ArticleIdList></Reference><Reference><Citation>Giamarellos-Bourboulis E.J., Netea M.G., Rovina N., Akinosoglou K., Antoniadou A., Antonakos N., Damoraki G., Gkavogianni T., Adami M.-E., Katsaounou P., et al. Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure. Cell Host Microbe. 2020;27:992&#x2013;1000.e3. doi: 10.1016/j.chom.2020.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.04.009</ArticleId><ArticleId IdType="pmc">PMC7172841</ArticleId><ArticleId IdType="pubmed">32320677</ArticleId></ArticleIdList></Reference><Reference><Citation>University of Glasgow&#x2014;University News&#x2014;First Results from Largescale Long-COVID Study.  [(accessed on 15 December 2023)].  Available online:  https://www.gla.ac.uk/news/headline_885987_en.html.</Citation></Reference><Reference><Citation>A Slater T., Straw S., Drozd M., Kamalathasan S., Cowley A., Witte K.K. Dying &#x2018;due to&#x2019; or &#x2018;with&#x2019; COVID-19: A cause of death analysis in hospitalised patients. Clin. Med. 2020;20:e189&#x2013;e190. doi: 10.7861/clinmed.2020-0440.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0440</ArticleId><ArticleId IdType="pmc">PMC7539724</ArticleId><ArticleId IdType="pubmed">32753516</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui D.S., Joynt G.M., Wong K.T., Gomersall C.D., Li T.S., Antonio G., Ko F.W., Chan M.C., Chan D.P., Tong M.W., et al. Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax. 2005;60:401&#x2013;409. doi: 10.1136/thx.2004.030205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2004.030205</ArticleId><ArticleId IdType="pmc">PMC1758905</ArticleId><ArticleId IdType="pubmed">15860716</ArticleId></ArticleIdList></Reference><Reference><Citation>Espinosa-Gonzalez A.B., Master H., Gall N., Halpin S., Rogers N., Greenhalgh T. Orthostatic tachycardia after COVID-19. BMJ. 2023;380:e073488. doi: 10.1136/bmj-2022-073488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-073488</ArticleId><ArticleId IdType="pubmed">36828559</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastie C.E., Lowe D.J., McAuley A., Winter A.J., Mills N.L., Black C., Scott J.T., O&#x2019;donnell C.A., Blane D.N., Browne S., et al. Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study. Nat. Commun. 2022;13:5663. doi: 10.1038/s41467-022-33415-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-33415-5</ArticleId><ArticleId IdType="pmc">PMC9556711</ArticleId><ArticleId IdType="pubmed">36224173</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>